Please assess the completion status of the following clinical trial:

Trial Title: Alvimopan Use in Polytraumatized Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 18 to 80~* Poly-traumatized patients~* Extubated patients after abdominal exploration~* Underwent Abdominal exploration, had colon resection with primary anastomosis with closure of abdomen~Exclusion Criteria:~* Mechanically ventilated patients~* Patient not expected to survive Glasgow Coma Scale = 3~* Pregnant patients~* Apache score \> 40 (observed mortality 100%) Saas Ahmed Naved et al 2011~* Vasopressor therapy~* Septic patients~* Thoracotomy~* Bogota bag~* Intravenous Drug Abuser (IVDA) as evidenced by urine toxicology upon admission to the Trauma Unit~* Patients with prior history of gastric surgery and/or colonic surgery~* Medical History: of severe cardiovascular disease, Renal diseases, Hepatitis C or Hepatic failure, Autoimmune disease, Crohn and Ulcerative Colitis (In view of the inflammation in the intestinal mucosal which may decrease optimal absorption of the medication) and or bowel obstruction~* Prior pancreatic anastomosis or gastric anastomosis; ostomy formation~* Chronic use of nonsteroidal anti-inflammatory drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Alvimopan (Type: EXPERIMENTAL): Patients in the study group will be administered a post operative dose of Alvimopan
- Placebo (Type: PLACEBO_COMPARATOR): Patients in the Placebo group will receive a placebo pill and will be compared with the study group

Based on this trial design, predict the completion outcome and termination type (if applicable).